Breast cancer resistance protein 1 (BCRP/ABCG2) is a drug efflux ABC-transporter with complementary action to P-gp, which is associated with resistance to many cancer therapies [17] and also reportedly expressed in melanoma tissue and cell lines [18, 19]. Here, ABCG2 is linked to melanoma.